调查代谢物概况和性结肠炎之间的因果关系:双向门德尔随机化研究
Parvin Zarei1, Zoha Kamali1,2, Ammar Hassanzadeh Keshteli3
1Department of Bioinformatics, Isfahan University of Medical Sciences, Isfahan, Iran.
Journal of medical signals and sensors
|September 15, 2025
概括
小高密度脂蛋白水平中的总脂质显示出与性结肠炎 (UC) 发展的潜在联系. 进一步的研究可能会将这些脂质确定为UC查和预防的生物标志物.
科学领域:
- 遗传学 是一个遗传学.
- 代谢学 代谢学 代谢学
- 胃肠病学 胃肠病学
背景情况:
- 性结肠炎 (UC) 的发展受到代谢生物标志物的影响,但因果关系尚不清楚.
- 研究血液代谢物和UC之间的关系对于了解疾病机制至关重要.
研究的目的:
- 通过双向门德尔随机化研究,评估503种血液代谢物和性结肠炎 (UC) 之间的因果关系.
- 确定潜在的代谢生物标志物用于UC查,预防和治疗点的发现.
主要方法:
- 利用了来自欧洲祖先队列的503种血液代谢物和UC的全基因组关联研究 (GWAS) 数据.
- 采用逆方差加权 (IVW) 方法进行初级分析和各种灵敏度分析 (MR-Egger,加权中位数) 以确保稳定性.
主要成果:
- 在小高密度脂蛋白水平 (S.HDL.L) 和UC发育 (OR = 1.167,P = 0.051) 中总脂质之间观察到边际显著的正相关性.
- 没有发现UC对研究代谢物的统计学上显著的因果作用.
结论:
- 在S.HDL.L中,总脂质可以作为UC查和预防的潜在循环生物标志物.
- 这些脂质可能是阐明UC病原体和识别药物标的候选分子.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
12.8K
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
8.7K
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
903
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
903
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
644
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
644
Drugs for Treatment of Ulcerative Colitis in IBD
463
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
463
